a day ago
CYTK
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 10%
#506 out of 5312 analysts
Average Return
+15.84%
Win Rate
63%60 out of 96
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Axsome Therapeutics IncAXSM | +133.51% | $103.26 | $241.12 | 2025-08-06 - 2026-06-29 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +103.02% | $16.56 | $33.62 | 2025-06-26 - 2026-06-25 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
a month ago
LEGN
a month ago
JAZZ
2 months ago
CORT
2 months ago
ALKS
2 months ago
TEVA
2 months ago
RPRX
3 months ago
AXSM
6 months ago
AXSM
7 months ago
JAZZ
8 months ago
ABBV
9 months ago
NBIX
9 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
2 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 7 | Strong Buy | $115.00 | +31.79% | Upgrades | a day ago |
Incyte CorpINCY | 4 | Hold | $113.00 | -1.45% | Maintains | 4 days ago |
Legend Biotech CorpLEGN | 5 | Strong Buy | $49.00 | +66.72% | Maintains | a month ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $48.00 | +39.94% | Initiates Coverage On | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 8 | Strong Buy | $307.00 | +29.14% | Upgrades | a month ago |
Corcept Therapeutics IncCORT | 2 | Strong Buy | $72.00 | -18.08% | Upgrades | 2 months ago |
Alkermes PLCALKS | 5 | Strong Buy | $48.00 | -8.62% | Maintains | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $42.00 | +26.09% | Maintains | 2 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | -0.16% | Maintains | 2 months ago |
Amneal Pharmaceuticals IncAMRX | 1 | Strong Buy | $19.00 | +9.89% | Initiates Coverage On | 2 months ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $259.00 | +7.42% | Maintains | 3 months ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +61.29% | Maintains | 3 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +29.38% | Maintains | 4 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +30.16% | Downgrades | 5 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | +4.71% | Maintains | 5 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +105.27% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +58.73% | Maintains | 6 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | -26.42% | Downgrades | 7 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | -13.49% | Maintains | 8 months ago |
Exelixis IncEXEL | 5 | Hold | $40.00 | -26.31% | Maintains | 8 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | 8 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | -53.26% | Maintains | a year ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | 2 years ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 3 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.